MEROPENEM APTAPHARMA 1000mg powder for injection / infusion solution medication leaflet

J01DH02 meropenem • Antiinfectives for systemic use | Other beta-lactam antibacterials | Carbapenems

Meropenem is an antibiotic from the carbapenem class, used to treat severe bacterial infections. It is effective against a broad spectrum of bacteria, including gram-positive, gram-negative, and anaerobic bacteria. It is often used in critical situations, such as nosocomial infections or life-threatening conditions.

This medication is indicated for the treatment of complicated infections, such as intra-abdominal infections, complicated urinary tract infections, bacterial meningitis, and skin and soft tissue infections. It is also used in the treatment of sepsis and hospital-acquired pneumonia, including ventilator-associated pneumonia.

Meropenem is administered intravenously and is well-tolerated by most patients. Common side effects include nausea, diarrhea, headache, and skin rashes. In rare cases, severe allergic reactions, seizures, or hematological disorders may occur.

It is important to use meropenem as prescribed, as overuse or misuse can lead to bacterial resistance. It is contraindicated in patients with known allergies to carbapenems or other beta-lactam antibiotics.

Patients should inform their doctor about any other medications they are taking or pre-existing conditions, such as renal impairment, as the dosage may need adjustment. Close monitoring during treatment is essential to prevent complications.

General data about MEROPENEM APTAPHARMA 1000mg

Substance: meropenem

Date of last drug list: 01-06-2025

Commercial code: W65978002

Concentration: 1000mg

Pharmaceutical form: powder for injection / infusion solution

Quantity: 10

Product type: generic

Price: 381.16 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FACTA FARMACEUTICI S.P.A. - ITALIA

Holder: APTA MEDICA INTERNACIONAL D.O.O. - SLOVENIA

Number: 11692/2019/02

Shelf life: 3 years; Dupa reconstituire - it is used immediately

Concentrations available for meropenem

1000mg, 1g, 2000mg, 500mg

Other substances similar to meropenem

Compensation lists for MEROPENEM APTAPHARMA 1000mg APTA MEDICA INTERNAC

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

381.16 RON

381.16 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

381.16 RON

381.16 RON

0.00 RON